← Back to Search

Electrotherapy

Electrotherapy for Chronic Pain

N/A
Waitlist Available
Led By Eric Johnson, DSc
Research Sponsored by Loma Linda University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects with Pain Group: >19 and <41 years of age
Subjects without Pain Group: > 19 and < 41 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change between baseline assessment and day eight post-enrollment
Awards & highlights

Study Summary

This trial will test a home TENS machine for pain relief in 60 adults, divided into 3 groups.

Who is the study for?
This trial is for Loma Linda University students aged 20-40, with chronic neck or upper body pain rated less than 5/10 on the pain scale. It's not for those outside this age range, using pain meds within six hours of data collection, with contraindications to electrotherapy, acute pain, severe chronic pain over 5/10 on the VAS, or currently receiving clinical treatment for pain.Check my eligibility
What is being tested?
The study tests Transcutaneous Electrical Nerve Stimulation (TENS) as a home treatment for reducing chronic neck or upper body pain. Sixty adults will be randomly placed into three groups: normal (no intervention), control (placebo), and intervention (active TENS use).See study design
What are the potential side effects?
While TENS is generally safe, potential side effects can include skin irritation where the electrodes are placed, tingling sensation during use that may be uncomfortable for some people and muscle soreness after use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 20 and 40 years old and experiencing pain.
Select...
I am between 20 and 40 years old and do not experience pain.
Select...
My pain level is less than 5 out of 10.
Select...
I do not have any sudden or severe pain.
Select...
I do not experience any pain.
Select...
I have chronic pain in my neck or upper body.
Select...
I am between 20 and 40 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between baseline assessment and day eight post-enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and change between baseline assessment and day eight post-enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Decrease in chronic subclinical neck or upper quadrant pain
Secondary outcome measures
Level of anxiety
Neck proprioception

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Subjects with Pain and InterventionExperimental Treatment1 Intervention
This group will include twenty participants with neck and/or upper quadrant pain that will receive transcutaneous electrical nerve stimulation treatment.
Group II: Subjects without PainActive Control1 Intervention
This group will include twenty participants with no neck and/or upper quadrant pain that will not receive transcutaneous electrical nerve stimulation treatment.
Group III: Subjects with Pain and No InterventionActive Control1 Intervention
This group will include twenty participants with neck and/or upper quadrant pain that will not receive transcutaneous electrical nerve stimulation treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcutaneous Electrical Nerve Stimulation
2013
N/A
~660

Find a Location

Who is running the clinical trial?

Loma Linda UniversityLead Sponsor
306 Previous Clinical Trials
260,928 Total Patients Enrolled
2 Trials studying Chronic Pain
42 Patients Enrolled for Chronic Pain
Eric Johnson, DScPrincipal InvestigatorLoma Linda University Health

Media Library

Transcutaneous Electrical Nerve Stimulation (Electrotherapy) Clinical Trial Eligibility Overview. Trial Name: NCT05382039 — N/A
Chronic Pain Research Study Groups: Subjects without Pain, Subjects with Pain and No Intervention, Subjects with Pain and Intervention
Chronic Pain Clinical Trial 2023: Transcutaneous Electrical Nerve Stimulation Highlights & Side Effects. Trial Name: NCT05382039 — N/A
Transcutaneous Electrical Nerve Stimulation (Electrotherapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05382039 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

In what population is eligibility for this trial being determined?

"Sixty individuals aged 20-40 suffering from chronic pain may participate in this study. Other criteria include being between 19 and 41 years of age, enrolled as a student at Loma Linda University, and having no reported pain."

Answered by AI

Are there still opportunities for participation in this investigation?

"According to the data on clinicaltrials.gov, this trial is not presently open for recruitment as it was last updated on November 29th 2022. Despite that, there are 403 other medical studies currently recruiting patients."

Answered by AI

Is this research project accepting individuals aged 40 or more?

"Based on the prerequisites for this investigation, only those aged between 20 and 40 can take part."

Answered by AI

Who else is applying?

What state do they live in?
Oregon
How old are they?
18 - 65
What site did they apply to?
Loma Linda University Health
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Effects of Electrotherapy on Pain, Anxiety, Motion and Disability in Adults With Neck or Upper Body Pain.
Eric Johnson 2023. "Effects of Electrotherapy on Pain, Anxiety, Motion and Disability in Adults With Neck or Upper Body Pain.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05382039.
All > Chronic Pain
~35 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top